NIMG-43. ADVANCED MULTI-PARAMETRIC HYPERPOLARIZED 13C/1H IMAGING OF GBM. (12th November 2021)
- Record Type:
- Journal Article
- Title:
- NIMG-43. ADVANCED MULTI-PARAMETRIC HYPERPOLARIZED 13C/1H IMAGING OF GBM. (12th November 2021)
- Main Title:
- NIMG-43. ADVANCED MULTI-PARAMETRIC HYPERPOLARIZED 13C/1H IMAGING OF GBM
- Authors:
- Autry, Adam
Vaziri, Sana
LaFontaine, Marisa
Gordon, Jeremy
Chen, Hsin-Yu
Villanueva-Meyer, Javier
Chang, Susan
Clarke, Jennifer
Xu, Duan
Lupo, Janine
Larson, Peder
Vigneron, Daniel
Li, Yan - Abstract:
- Abstract: INTRODUCTION: The goal of this study was to characterize progressive and pseudoprogressive GBM using multi-parametric hyperpolarized (HP)- 13 C / 1 H MRI. METHODS: Dynamic HP- 13 C MRI was acquired from 13 patients with progressive GBM [patients (scans): 2(3) IDH-mutant; 11(13) IDH-wildtype] and 2 IDH-wildtype patients (3 scans) demonstrating pseudo-progression following intravenous injection of HP [1- 13 C]pyruvate. Frequency-selective echo-planar imaging (3s temporal resolution, 3.38 cm 3 spatial resolution) captured [1- 13 C]pyruvate metabolism to [1- 13 C]lactate and 13 C-bicarbonate in the brain. Dynamic 13 C data were kinetically modeled to obtain the pyruvate-to-lactate conversion rate constant k PL and temporally summed to calculate 13 C-metabolite percentiles and ratios (linearly interpolated 2x in-plane). 1 H imaging included T2, post-Gd T1, perfusion (nCBV, %recovery), diffusion (ADC), and lactate-edited spectroscopy (CNI, choline-to-NAA index; 1 H-lactate). The normal-appearing white matter (NAWM), non-enhancing lesion (NEL), and contrast-enhancing lesion (CEL) were segmented from 1 H images. 13 C-resolution masks were iteratively applied on a voxel-wise basis to evaluate 1 H imaging parameters within each ROI and multi-parametric data were collectively evaluated using a mixed effects model in R. RESULTS: Progressive IDH-mutant GBM compared to wildtype counterparts displayed increased perfusion %recovery ( p < 0.001) and k PL ( p < 0.01), together withAbstract: INTRODUCTION: The goal of this study was to characterize progressive and pseudoprogressive GBM using multi-parametric hyperpolarized (HP)- 13 C / 1 H MRI. METHODS: Dynamic HP- 13 C MRI was acquired from 13 patients with progressive GBM [patients (scans): 2(3) IDH-mutant; 11(13) IDH-wildtype] and 2 IDH-wildtype patients (3 scans) demonstrating pseudo-progression following intravenous injection of HP [1- 13 C]pyruvate. Frequency-selective echo-planar imaging (3s temporal resolution, 3.38 cm 3 spatial resolution) captured [1- 13 C]pyruvate metabolism to [1- 13 C]lactate and 13 C-bicarbonate in the brain. Dynamic 13 C data were kinetically modeled to obtain the pyruvate-to-lactate conversion rate constant k PL and temporally summed to calculate 13 C-metabolite percentiles and ratios (linearly interpolated 2x in-plane). 1 H imaging included T2, post-Gd T1, perfusion (nCBV, %recovery), diffusion (ADC), and lactate-edited spectroscopy (CNI, choline-to-NAA index; 1 H-lactate). The normal-appearing white matter (NAWM), non-enhancing lesion (NEL), and contrast-enhancing lesion (CEL) were segmented from 1 H images. 13 C-resolution masks were iteratively applied on a voxel-wise basis to evaluate 1 H imaging parameters within each ROI and multi-parametric data were collectively evaluated using a mixed effects model in R. RESULTS: Progressive IDH-mutant GBM compared to wildtype counterparts displayed increased perfusion %recovery ( p < 0.001) and k PL ( p < 0.01), together with reduced 1 H-lactate ( p < 0.001) and pyruvate percentile ( p < 0.01), in the T2 lesion. Among IDH-wildtype progressive GBM, the CEL was distinguished from NEL/NAWM by increased nCBV ( p < 0.05/0.001), 1 H-lactate ( p < 0.05/0.001); and decreased bicarbonate / lactate ( p < 0.05/0.001). The CEL and NEL were collectively distinguished from NAWM by elevated CNI (p < 0.001/0.001), ADC ( p < 0.05/0.001), pyruvate percentile ( p < 0.001/0.001), lactate percentile ( p < 0.001/0.001), and relative lactate / pyruvate ( p < 0.001/0.05). Psuedo-progressive IDH-wildtype GBM displayed lower k PL (T2 Lesion; p < 0.01) and nCBV (CEL; p < 0.01) compared to progressive GBM. CONCLUSION: HP- 13 C parameters can potentially augment proton imaging and demonstrated Warburg-associated metabolic alterations. … (more)
- Is Part Of:
- Neuro-oncology. Volume 23: Supplement 6(2021)
- Journal:
- Neuro-oncology
- Issue:
- Volume 23: Supplement 6(2021)
- Issue Display:
- Volume 23, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 23
- Issue:
- 6
- Issue Sort Value:
- 2021-0023-0006-0000
- Page Start:
- vi138
- Page End:
- vi138
- Publication Date:
- 2021-11-12
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noab196.542 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20207.xml